Blink Health
Blink Health is a healthcare technology company. Its BlinkRx platform offers discounted prescription medications with price comparison and home delivery.
Secondary Market Price
How Blink Health Measures Up
To help you manage your Blink Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Blink Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Blink Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Blink Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Blink Health operates as a digital healthcare platform focused on the prescription drug market. The company provides a service connecting pharmaceutical companies directly with patients, offering transparent pricing, free home delivery, and support for branded medications. It aims to address administrative hurdles for patients and providers by managing processes like coverage checks and prior authorizations. Founded in 2014 by brothers Geoffrey and Matthew Chaiken, the New York-based company has since expanded to include multiple office locations across the U.S. and partners with a network of 35,000 pharmacies. To date, Blink Health has raised $165 million in funding, with its last known valuation at $600 million.
The company continues to form partnerships with pharmaceutical manufacturers to facilitate access to new medications. For example, Blink Health partnered with Bayer to provide access to Lynkuet, a menopause therapy, and with Scienture LLC to expand access to Arbli™, an oral suspension of losartan potassium. The platform has also been used to enable Medicare patients to access specific drugs not covered by their insurance, such as Phathom Pharmaceuticals' VOQUEZNA, which led to an increase in cash prescriptions for the drug. Blink Health's leadership frequently participates in industry events, such as the JPM Healthcare Conference, to engage with partners on topics of drug commercialization, pricing, and distribution.
- 8VC
- BoxGroup
- Burch Creative Capital
- MedImpact HealthCare Systems
- Melo7 Tech Partners
- Teamworthy Ventures
- 1789 Capital
- Cercano Management
- Fidelity Investments
- Sweetwater Private Equity
- Co-Founder, Geoffrey Chaiken
- Co-Founder, Matthew Chaiken
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Blink Health worth joining?
Evaluating an offer from a private company like Blink Health involves understanding the potential of your equity compensation. Platforms like Prospect can help you compare potential earnings and model the future value of your equity to make a more informed decision.
What should I do with my Blink Health stock?
Managing private company stock like Blink Health's involves complex decisions around exercising options, tax planning, and timing potential sales. Platforms like Prospect provide customized strategies to help you navigate these choices and maximize your equity's value.
Can you sell Blink Health stock?
Selling stock in a private company like Blink Health is typically possible through secondary markets or company-organized tender offers, though it is less straightforward than with public stocks. Prospect offers tools to help you optimize selling shares during events like tender offers to achieve the best possible tax outcome.
How can I find the value of my Blink Health stock?
Valuing stock in a private company like Blink Health is difficult because it doesn't trade on a public exchange. You can use a platform like Prospect, which uses proprietary models trained on venture capital data to forecast the future value of your private company shares.
What is Blink Health's equity worth?
The exact worth of private equity from a company like Blink Health is not public information and can be highly volatile. Services like Prospect can help you estimate a range of potential values by analyzing various data points and projecting likely outcomes for the company.
What is Blink Health's stock ticker symbol?
As a private company, Blink Health is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they undergo an Initial Public Offering (IPO).
Can I buy or sell Blink Health stock?
While you generally cannot buy shares of a private company like Blink Health on the open market, selling is sometimes possible through secondary markets or tender offers. Platforms like Prospect can help you create a strategy for when and how to sell your shares to optimize your financial outcome.
What is the criteria to buy or invest in Blink Health stock?
Investing in a private company like Blink Health is usually limited to accredited investors participating in private funding rounds or to employees who receive equity as compensation. If you are an employee with equity, platforms like Prospect can help you manage it, but they do not facilitate the initial investment.
